hyperlipidemia
Conditions
Interventions
control group:Placebo
Sponsors
Guangdong Provincial Hospital of Traditional Chinese Medical
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18-75 years; 2. Meet the diagnosis of wet syndrome; 3. Meet the diagnosis of dyslipidemia; 4. Cardiovascular risk assessment is medium risk to low risk; 5. Volunteer to participate in the research of this subject and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Those who have been using lipid-lowering drugs within 3 months before being selected. 2. Patients with nephrotic syndrome, hypothyroidism, renal failure, liver disease, systemic lupus erythematosus, myeloma, glycogen accumulation disorder, lipodystrophy, acute porphyria and polycystic ovary syndrome. 3. Patients who are using drugs related to blood lipid metabolism, such as diuretics, beta blockers, glucocorticoids, metformin, insulin, and contraceptives. 4. After treatment, the systolic blood pressure is still >= 180mmHg or the diastolic blood pressure is still >= 110mHg. 5. GLU still >= 11.1mmol/L after oral medication. 6. Those with TG >= 5.65mmol/L. 7. Patients with serious diseases of the heart, liver, kidneys, hematopoietic system, immune system, etc. 8. Women who are pregnant or breastfeeding or who plan to become pregnant during the trial period or whose spouse plans to become pregnant. 9. People with allergies, possible allergies to this medicine, or mental illness. 10. Others who cannot cooperate for a long time.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| LDL-C;TG;TC;HDL-C; | — |
Secondary
| Measure | Time frame |
|---|---|
| BMI;BP;GLU;INS;UA;CRP;TNF-a;IL-6; | — |
Countries
China
Contacts
Public ContactXinyan Chen
Guangdong Province Traditional Chinese Medical Hospital
Outcome results
None listed